-
Endpoints News2 weeks ago
Top HHS official makes impassioned pitch to take on China biotech
Senior HHS official and head of Medicare Chris Klomp didn’t mince words when he called competition with China’s ascending biotech industry “a war.” Klomp’s comments, made...
-
Endpoints News2 weeks ago
Biopharma industry pushes back on FDA’s ‘America First’ user fee proposals
Biopharma industry representatives are taking issue with some of the FDA’s more political proposals in the next round of user fee agreements, particularly ones that would...
-
Endpoints News2 weeks ago
Recordati says it’s received a $12B+ takeover bid
Milan-based Recordati confirmed Thursday that it has received a buyout offer north of $12 billion. The company said in a press release that private equity firm...
-
Endpoints News2 weeks ago
UCB picks Georgia for $2B biologics site; AbbVie exec visits China
UCB has selected Gwinnett County, GA, as the location for its new biologics factory. The 460,000-square-foot facility is expected to cost $2 billion and will supply...
-
Endpoints News2 weeks ago
New tech, familiar problems
I’ve been on the hunt for a referral to see a new physical therapist. So I decided to try out Doctronic, which markets itself as an...
-
Endpoints News2 weeks ago
Kodiak’s Phase 3 eye drug success; Innate discontinues anti-CD20 program
Plus, news about Astellas’ setidegrasib and Anavex: 📈 Kodiak’s eye drug win: The biotech’s experimental drug Zenkuda, whose scientific name is tarcocimab tedromer, beat a sham...
-
Endpoints News2 weeks ago
Limbic aims to show AI beats humans in delivering therapy
A March study in Nature Medicine showed that AI designed for therapy can deliver better care than human clinicians in a specific type of therapy. UK-based...
-
Endpoints News2 weeks ago
Post-Hoc: It’s time to make ACIP serious again
Who knows what’s going to happen to the Advisory Committee on Immunization Practices? Former member Robert Malone suggested in a string of social media posts last...
-
Endpoints News2 weeks ago
Oral peptides biotech Pinnacle Medicines gets $89M from US, China investors
The pill version of Novo Nordisk’s blockbuster Wegovy showed what was possible when drug chemists turned peptides into oral molecules. Now investors have found their next...
-
Endpoints News2 weeks ago
FDA gives Denali accelerated approval for rare disease drug
The FDA granted accelerated approval to Denali Therapeutics’ rare disease drug Avlayah, bucking a recent trend of rejections in the space that has put the agency...
Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off
